- Home
- PLSE vs RXO Comparison
PLSE vs RXO Comparison
Compare PLSE & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLSE | RXO |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.0B |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PLSE | RXO |
|---|---|---|
| Price | $49.83 | $21.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 21 |
| Target Price | ★ $54.00 | $24.56 |
| AVG Volume (30 Days) | 570.3K | ★ 1.4M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.81 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,742,000,000.00 |
| Revenue This Year | $477.71 | $19.10 |
| Revenue Next Year | $233.00 | $9.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.20 |
| 52 Week Low | $12.56 | $10.43 |
| 52 Week High | $58.90 | $29.90 |
Technical Indicators
Market Signals| Indicator | PLSE | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 48.92 |
| Support Level | $49.01 | $19.08 |
| Resistance Level | $57.82 | $23.63 |
| Average True Range (ATR) | 3.21 | 0.94 |
| MACD | -0.80 | 0.22 |
| Stochastic Oscillator | 16.43 | 67.03 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.